| Role |
Name |
Disclosure |
Details |
| Author | Howard A Crystal, MD, Professor, Departments of Neurology and Pathology, State University of New York Downstate | Pfizer Myriad | Details | | Medical Editor | Robert A Hauser, MD, Professor, Departments of Neurology, Pharmacology, and Experimental Therapeutics, Director, Parkinson's Disease and Movement Disorders Center, University of South Florida and Tampa General Healthcare | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Richard J Caselli, MD, Professor, Department of Neurology, Mayo Medical School, Rochester, MN; Chair, Department of Neurology, Mayo Clinic of Scottsdale | Nothing to disclose | Details | | CME Editor | Matthew J Baker, MD, Consulting Staff, Collier Neurologic Specialists, Naples Community Hospital | Nothing to disclose | Details | | Chief Editor | Helmi L Lutsep, MD, Associate Professor, Department of Neurology, Oregon Health and Science University; Associate Director, Oregon Stroke Center | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Robert A Hauser, Medical Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Richard J Caselli, Managing Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Matthew J Baker, CME Editor |
The contributor discloses no conflict of interest. |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Helmi L Lutsep, Chief Editor |
The contributor discloses no conflict of interest. |
|